Clarification11 Aug 2026, 06:23 pm
Sai Parenterals: No IPO Fund Use Deviation for Q1 FY27
AI Summary
Sai Parenterals Ltd has filed a statement confirming no deviation or variation in the utilization of funds raised through its Initial Public Offer (IPO) for the quarter ended June 30, 2026. The company raised ₹2,850 million via IPO between March 24-27, 2026. The report details the allocation and utilization against original objects, including capacity expansion, R&D center establishment, loan repayment, working capital, and general corporate purposes. No significant deviations were noted in the utilization for the specified period.
Key Highlights
- No deviation in IPO fund utilization for Q1 FY27.
- Total IPO funds raised: ₹2,850 million.
- Funds utilized across expansion, R&D, debt repayment, and working capital.
- Statement filed as per SEBI (LODR) Regulations, 2015.
Price Impact
More from SAIPARENT